Latest KFF Health News Stories
It’s Not Just Insulin: Diabetes Patients Struggle To Get Crucial Supplies
The latest technology makes managing Type 1 diabetes much easier. But managing insurance company rules for the supplies is a big obstacle for some patients.
Millions Of Diabetes Patients Are Missing Out On Medicare’s Nutrition Help
Health experts say the little-used benefit represents a lost opportunity for older adults to improve their health — and for the program to save money by preventing costly complications from diabetes and chronic kidney disease.
Millones con diabetes no aprovechan programa nutricional de Medicare
Hay unos 15 millones de beneficiarios de Medicare que viven con diabetes, pero solo unos 100,000 se han inscripto para usar este beneficio que, al parecer, tiene buenos resultados.
Tecnología casera ofrece más libertad a los pacientes para controlar su diabetes
La diabetes tipo 1 es una condición crónica que requiere un estricto control de la glucosa y la administración de la cantidad de insulina precisa. Pacientes crearon un sistema para mantener ese equilibrio vital.
DIY Tech Gives People More Freedom In Managing Diabetes
People with diabetes say they’ve been waiting for years for better technology to manage their chronic condition. Tired of waiting, some tech-savvy, do-it-yourselfers are constructing their own devices using open-source programming instructions.
On A Mission To Help People Control Diabetes — And Save Money On Insulin
Patients with Type 2 diabetes are often steered toward medicine or insulin treatment. But with additional support, it’s possible to use diet and exercise to control blood sugar. The rising price of insulin drives patients to lower their dependence on the medicine.
Watch: High Cost Of Insulin Sends Americans To Canada To Stock Up
KHN, in collaboration with PBS NewsHour, reports on the skyrocketing cost of insulin — and the trend’s deadly consequences. The price in the U.S. nearly doubled from 2012 to 2016, prompting some patients and activists to travel to Canada, where insulin can be 90% cheaper.
Readers And Tweeters Parse Ideas — From Snakebites To Senior Suicide
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Amputaciones diabéticas: una “métrica vergonzosa” de la atención inadecuada
Aunque el pronóstico de la diabetes se ha vuelto menos grave para las personas que reciben atención médica, para los que no, la condición muchas veces lleva a amputaciones que podrían prevenirse.
Diabetic Amputations A ‘Shameful Metric’ Of Inadequate Care
In California, people who are black or Latino are more than twice as likely as whites to undergo amputations related to diabetes, a Kaiser Health News analysis found. The pattern is not unique to California.
Grupos denuncian atención médica y de salud mental deficiente a los detenidos por ICE
Grupos de derechos civiles denuncian que los inmigrantes detenidos en un centro de Adelanto, California, no reciben el urgente cuidado médico y mental que necesitan.
Is Insulin’s High Cost Keeping Diabetes Patients From Taking Their Medicine?
An estimated 1.25 million Americans have Type 1 diabetes and cannot live without insulin. Sen. Kamala Harris’ claim that 1 in 4 diabetes patients cannot afford their insulin is a shockingly high number, so we decided to dig into the sparse data.
Watchdogs Cite Lax Medical And Mental Health Treatment Of ICE Detainees
The Adelanto ICE Processing Center houses nearly 2,000 people in California. Federal, state and watchdog reviews say the Florida-based firm that runs the facility fails to provide adequate health care.
The Blame Game: Everyone And No One Is Raising Insulin Prices
During Wednesday’s House subcommittee hearing on insulin price hikes, drug makers and benefits managers pointed fingers at each other for the last decade’s 300% price increase, frustrating congressional representatives.
Analysis: Why Americans Shouldn’t Feel Grateful For $137 Insulin
Only by the bizarre logic of the U.S. pharmaceutical industry does this drug count as any kind of generic.
How Much Difference Will Eli Lilly’s Half-Price Insulin Make?
Eli Lilly released a half-price generic version of its own short-acting insulin. At $137.35 per vial, the generic insulin is priced at about the same level as Humalog was in 2012.
Pacientes experimentan con drogas recetadas para luchar contra la vejez
Aún no se han realizado ensayos clínicos rigurosos a gran escala para estudiar el proceso de envejecimiento. Así y todo, pacientes experimentan con drogas para detener el paso del tiempo.
Patients Experiment With Prescription Drugs To Fight Aging
Doctors and patients say they’re compelled to use off-label meds as research goes unfunded.
Estadounidenses van a México a comprar insulina por un costo mucho más bajo
Millones cruzan la frontera para tratamientos y para comprar medicinas. La pregunta es si es una práctica legal. En Utah establecen turismo médico.
Americans Cross Border Into Mexico To Buy Insulin At A Fraction Of U.S. Cost
For one patient, a three-month supply of insulin is $3,700 in the U.S. versus $600 in Mexico. But is it legal?
